Analyst Ratings For Clementia Pharmaceuticals (NASDAQ:CMTA) (NASDAQ:CMTA)
Today, B. Riley initiated coverage on Clementia Pharmaceuticals (NASDAQ:CMTA) (NASDAQ:CMTA) with a Buy with a price target of $25.00.
Some recent analyst ratings include
- 3/28/2018-B. Riley initiated coverage with a Buy rating.
- 11/14/2017-Wedbush Reiterated Rating of Outperform.
- 8/31/2017-BTIG Research initiated coverage with a Buy rating.
- 8/28/2017-Leerink Swann initiated coverage with a Outperform rating.
- 8/28/2017-Morgan Stanley initiated coverage with a Overweight rating.
Recent Trading Activity for Clementia Pharmaceuticals (NASDAQ:CMTA) (NASDAQ:CMTA)
Shares of Clementia Pharmaceuticals (NASDAQ:CMTA) closed the previous trading session at 16.91 up +0.42 2.55% with 16.649999618530273 shares trading hands.